Evidence map›Paper›PMID 19703982›Full record

ArticleInfection and immunity2009

Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice.

D M Magnani, J S Harms, M A Durward, G A Splitter

Abstract read
In one paragraph

Article in Infection and immunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Protection against virulentClinical and experimental vaccine research · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Controlling the Colonization ofAnimals : an open access journal from MDPI · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Proteomic Analysis of Vesicle-ProducingFrontiers in microbiology · 2020
    Article
  14. Frontiers in microbiology · 2018
    Article
  15. Article
  16. Review
  17. Article
  18. Application of radiation technology in vaccines development.Clinical and experimental vaccine research · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

D M MagnaniDepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, AHABS, 1656 Linden Drive, Madison, WI 53706, USA.
J S Harms
M A Durward
G A Splitter

Funding

Vaccines and Therapies Against BotulismU54AI057153 · NIAID · UNIVERSITY OF CHICAGO · PI KANABROCKI, JOSEPH A. · 2003 to 2013
$87.6M
Brucella epitope recognition by CD8+ T cellsR01AI073558 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI HARMS, JEROME SCOTT, SMITH, JUDITH ANNE · 2008 to 2016
$3.3M
TIR domain containing protein from Brucella melitensisR21AI088038 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI HARMS, JEROME SCOTT · 2010 to 2011
$406k
NIAID NIH HHS 1R01AI073558NIAID NIH HHS 1-U54-AI-057153NIAID NIH HHS R01 AI073558NIAID NIH HHS R21 AI088038NIAID NIH HHS U54 AI057153
6 · The paper itself

Abstract

Brucella spp. are gram-negative bacteria that cause the most frequent zoonotic disease worldwide, with more than 500,000 human infections yearly; however, no human vaccine is currently available. As with other intracellular organisms, cytotoxic mechanisms against infected cells are thought to have an important role in controlling infection and mediating long-term immunity. Live attenuated strains developed for use in animals elicit protection but retain unacceptable levels of virulence. Thus, the optimal design for a brucellosis vaccine requires a nonliving vaccine that confers effective immunity. Historically, inactivation methods such as chemical or heat treatment successfully impair Brucella reproductive capacity; nevertheless, metabolically inactive vaccines (subunit or killed) present very limited efficacy. Hence, we hypothesized that bacterial metabolism plays a major role in creating the proper antigenic and adjuvant properties required for efficient triggering of protective responses. Here, we demonstrate that inactivation of Brucella melitensis by gamma-irradiation inhibited its replication capability and yet retained live-Brucella protective features. Irradiated Brucella possessed metabolic and transcriptional activity, persisted in macrophages, generated antigen-specific cytotoxic T cells, and protected mice against virulent bacterial challenge, without signs of residual virulence. In conclusion, pathogen metabolic activity has a positive role in shaping protective responses, and the generation of inactivated and yet metabolically active microbes is a promising strategy for safely vaccinating against intracellular organisms such as B. melitensis.

Indexed as

Gamma RaysAnimalsBrucella melitensisBrucella VaccineBrucellosisCytotoxicity, ImmunologicMiceVaccines, AttenuatedVirulence FactorsBrucella VaccineVaccines, AttenuatedVirulence Factors

Identifiers

PMID19703982
PMCPMC2772552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.